ClinicalTrials.Veeva

Menu

Treatment of Keratosis Pilaris With 810 nm Diode Laser (KP)

Northwestern University logo

Northwestern University

Status

Completed

Conditions

Keratosis Pilaris (KP)

Treatments

Device: Diode Laser

Study type

Interventional

Funder types

Other

Identifiers

NCT01281644
MA111810

Details and patient eligibility

About

The investigators hope to establish whether or not the diode laser, a longer-wavelength laser, is effective in treating keratosis pilaris, and hopefully opening a door into the discussion and management of this skin condition. The primary outcome of interest is the difference in the overall blind rater severity scores of the treated versus the untreated sites. The secondary outcome of interest is the change in the patient's self-rated severity score of the treated site. To account for potential natural disease progression or regression, the investigators will also compare patient mean changes to the mean changes in severity scores of the untreated site.

Enrollment

23 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject is age 18 to 65
  • Subject has diagnosis of keratosis pilaris involving both arms
  • Subject has Fitzpatrick Skin Type I - III
  • Subject is in good health
  • Subject has the willingness and ability to understand and provide informed consen

Exclusion criteria

  • Under 18 or over 65 years of age
  • Subjects with Fitzpatrick Skin Type greater than III
  • Subjects who have received any laser therapy to the armsin the past year
  • Subjects with concurrent diagnosis of another skin condition or malignancy
  • Subjects with tan or sunburn over the upper arms in the past month
  • Subjects with open, non-healing sores or infections at any skin site
  • Subjects who are unable to understand the protocol or give informed consent
  • Subjects who take oral photosensitizing medications or who apply topical photosensitizing medications to either arm

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

23 participants in 2 patient groups

No Laser Treatment
No Intervention group
45-60 J Diode Laser Therapy
Active Comparator group
Description:
Diode laser therapy will be initiated at 45-60 J for 30 ms to 100 ms.
Treatment:
Device: Diode Laser

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems